{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicwxw4fwtl73u4aoawqjxdci7f53uuz6l5ewird3zsl67qxujxeyy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mesghikuba52"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihu7am3sv2wj4sdpy4h2pmbjg4nm6urzjzn3zqoi3iqwus7xxn2e4"
    },
    "mimeType": "image/jpeg",
    "size": 113944
  },
  "path": "/2026/02/13/disc-medicine-fda-decision/?utm_campaign=rss",
  "publishedAt": "2026-02-13T20:29:19.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Breaking News",
    "biotechnology",
    "FDA",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "The FDA has rejected a rare disease therapy from Disc Medicine, an early recipient of a commissioner's voucher from the agency.",
  "title": "STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher",
  "updatedAt": "2026-02-13T23:23:12.000Z"
}